[On the effect of neurotropic substances on lipid metabolism and experimental arteriosclerosis].
D000818:Animals; D001011:Aorta / Q000032:analysis; D001161:Arteriosclerosis / Q000378:metabolism*; D002784:Cholesterol / Q000032:analysis / Q000097:blood; D004558:Electric Stimulation; D004594:Electrophysiology; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D006624:Hippocampus / Q000502:physiology; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007031:Hypothalamus / Q000502:physiology; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis / Q000097:blood; D008722:Methods; D010276:Parasympatholytics / Q000494:pharmacology*; D011817:Rabbits; D013566:Sympathomimetics / Q000494:pharmacology*
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D006993:Hypnotics and Sedatives; D008055:Lipids; D010276:Parasympatholytics; D013566:Sympathomimetics; D002784:Cholesterol
O vliianii neĭrotropnykh sredstv na lipidnyĭ obmen i éksperimental'nyĭ ateroskleroz.